- Pathological Significance of Tissue Trapped in Retrieved OptEase Vena Cava Filter at 18th Day after Installation in Patient with Deep Vein Thrombosis
-
Park SM, Son JW, Hong KS, Choi KC
- KMID: 2419128
- Yonsei Med J.
- 2017 May;58(3):662-664.
- doi: 10.3349/ymj.2017.58.3.662
The retrievable type of inferior vena cava filter has been widely used to prevent pulmonary thromboembolism in patients with deep vein thrombosis and contraindication of anticoagulation. Physicians make considerable efforts... -
- CITED
-
- Close
- SHARE
-
- Close
- Endovascular Treatment for Iliac Vein Compression Syndrome: a Comparison between the Presence and Absence of Secondary Thrombosis
-
Lou WS, Gu JP, He X, Chen L, Su HB, Chen GP, Song JH, Wang T
- KMID: 1088724
- Korean J Radiol.
- 2009 Apr;10(2):135-143.
- doi: 10.3348/kjr.2009.10.2.135
OBJECTIVE: To evaluate the value of early identification and endovascular treatment of iliac vein compression syndrome (IVCS), with or without deep vein thrombosis (DVT). MATERIALS AND METHODS: Three groups of... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy
-
Yoon I, Yim HJ, Kim JN, Park SM, Kim JH, Lee SH, Chung HH, Lee HS, Lee SW, Choi JH
- KMID: 1776819
- Korean J Hepatol.
- 2009 Mar;15(1):90-95.
- doi: 10.3350/kjhep.2009.15.1.90
Portal vein invasion is a grave prognostic indicator in the setting of hepatocellular carcinoma (HCC). There is currently no effective method for preventing the invasion of HCC into the main... -
- CITED
-
- Close
- SHARE
-
- Close
- A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function
-
Yang H, Woo HY, Lee SK, Han JW, Jang B, Nam HC, Lee HL, Lee SW, Song DS, Song MJ, Oh JS, Chun HJ, Jang JW, Lozada A, Bae SH, Choi JY, Yoon SK
- KMID: 2413116
- Clin Mol Hepatol.
- 2017 Jun;23(2):128-137.
- doi: 10.3350/cmh.2016.0071
BACKGROUND/AIMS: Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS)... -
- CITED
-
- Close
- SHARE
-
- Close
